Resmed Inc’s recently made public that its Director FARRELL PETER C unloaded Company’s shares for reported $0.5 million on Jan 07 ’26. In the deal valued at $248.83 per share,2,000 shares were sold. As a result of this transaction, FARRELL PETER C now holds 66,773 shares worth roughly $17.01 million.
Then, Farrell Michael J. sold 4,991 shares, generating $1,240,065 in total proceeds. Upon selling the shares at $248.46, the Chairman and CEO now owns 466,223 shares.
Before that, Peter C Farrell bought 2,000 shares. Resmed Inc shares valued at $497,580 were divested by the Director at a price of $248.79 per share.
Robert W. Baird downgraded its Resmed Inc [RMD] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. CLSA also remained covering RMD and has increased its forecast on September 02, 2025 with a “an Outperform” recommendation from previously “Hold” rating. RBC Capital Mkts revised its rating on July 15, 2025. It rated RMD as “an Outperform” which previously was an “a Sector perform”.
Price Performance Review of RMD
On Tuesday, Resmed Inc [NYSE:RMD] saw its stock fall -1.23% to $254.67. Over the last five days, the stock has gained 2.20%. Resmed Inc shares have risen nearly 8.92% since the year began. Nevertheless, the stocks have risen 5.73% over the past one year.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-12-31, growing by 1.26 million shares to a total of 11.67 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 10.42 million shares. There was a rise of 10.76%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $280 price target.
